Urinary metabolomics provide insights into coronary artery disease in individuals with type 1 diabetes

Anni A Antikainen, Stefan Mutter, Valma Harjutsalo, Lena M Thorn, Per-Henrik Groop, Niina Sandholm, the FinnDiane Study Group · 2024

Read Urinary metabolomics provide insights into coronary artery disease in individuals with type 1 diabetes by Anni A Antikainen, Stefan Mutter, Valma Harjutsalo, Lena M Thorn, Per-Henrik Groop, Niina Sandholm, the FinnDiane Study Group (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11590341.txt.

Description

Anni Antikainen and co-authors, with a Finnish study group, tracked urine chemistry in 2024 for signs of future heart disease in type 1 diabetes. People with this diabetes face a high risk of blocked heart arteries. Urine is less tightly controlled than blood, so early disease marks may show there first. The team studied 2,501 adults and tested fifty-four urine chemicals at the start.

Over ten years, 209 people developed heart artery disease. Four urine chemicals stood out: one linked to higher risk, and three to lower risk at five or ten years. Network checks tied some of these marks to age, kidney function, and cell stress. Adding the marks improved risk forecasts, mainly over shorter spans. The authors say urine testing could sharpen early warning for this group.

Catalog record

CREATORAnni A Antikainen, Stefan Mutter, Valma Harjutsalo, Lena M Thorn, Per-Henrik Groop, Niina Sandholm, the FinnDiane Study Group
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11590341

Browse the full library · About the Tower of Babel